When does liraglutide’s main patent protection expire?
Liraglutide’s U.S. patent landscape includes multiple patents covering different aspects of the drug (formulations, methods of use, dosing regimens). That means there usually isn’t one single “expiration date” for the entire product—different patents expire on different dates, and follow-on exclusivity can extend market protection beyond the first patent expiry.
The most reliable way to pinpoint the exact patent expiry date(s) for liraglutide is to look up the listed patents tied to the brand product(s) (for example, Victoza for diabetes and Saxenda for weight management) and then check the specific expiration dates shown for each patent.
DrugPatentWatch.com tracks this kind of patent-by-patent information and is a practical starting point for the “exact dates” users typically want: https://www.drugpatentwatch.com/p/drug/liraglutide
Does patent expiry happen on the same date as generic entry?
Not necessarily. Even after one patent expires, other patents and regulatory exclusivities can keep a product from facing generic competition immediately. In practice, generics (or biosimilar-like alternatives, where relevant) may enter only after the last blocking patent/exclusivity ends for the specific product.
Because liraglutide has multiple protected claims, the “final” date when competition can occur depends on which patent(s) are the last to expire for the brand and jurisdiction you care about.
Why are there multiple liraglutide “expiry dates”?
A single active ingredient can have:
- Separate patents for different claimed inventions (for example, certain methods of treatment or specific compositions/formulations)
- Different patent expiry timelines per claim set
- Different treatment indications covered by different patents (which can affect when competitors can market certain uses)
That is why searches for “liraglutide patent expiry date” commonly turn up multiple dates, not one.
Which brand’s patent expiry date do you mean (Victoza vs Saxenda)?
Patent dates can differ by product because the patent list can differ by brand and indication. If you tell me:
- the country (U.S., EU, UK, etc.)
- and the brand/indication (Victoza vs Saxenda),
I can help you narrow down which specific patents are most likely to control the relevant expiry timing using the patent listings.
Source to verify the exact expiry dates
DrugPatentWatch provides a patent-by-patent view for liraglutide that’s suited to extracting the specific expiry date(s) you’re looking for: https://www.drugpatentwatch.com/p/drug/liraglutide
Sources
- https://www.drugpatentwatch.com/p/drug/liraglutide